查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1564094

X光結晶的全球市場

X-Ray Crystallography
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球 X 光結晶市場預計將達到 20 億美元

全球X光結晶市場預估2023年為9.373億美元，預估至2030年將達20億美元，2023-2030年分析期間複合年成長率為11.4%。藥品最終用途是本報告分析的細分市場之一，預計複合年成長率為 10.9%，到分析期結束時將達到 9.445 億美元。分析期內，生物技術最終用途領域的複合年成長率預計為 12.4%。

美國市場預估為2.518億美元，中國預期複合年成長率為10.5%

預計 2023 年美國X光結晶市場規模將達 2.518 億美元。中國作為世界第二大經濟體，預計在2023-2030年分析期間複合年成長率為10.5%，預計到2030年市場規模將達到3.033億美元。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 10.1% 和 9.4%。在歐洲，德國的複合年成長率預計為 8.0%。

全球 X 光結晶市場 – 主要趨勢與促進因素總結

為什麼 X光結晶對於科學研究至關重要？

X光結晶是一種用於確定結晶原子和分子結構的強大分析技術。它是科學研究的重要工具，特別是在化學、生物學和材料科學等領域。在原子層次上理解分子結構的能力對於藥物發現、蛋白質分析和材料開發至關重要。在製藥業，X光結晶經常用於識別生物聚合物的結構，這對於標靶藥物的開發很有用。複雜疾病數量的不斷增加以及對先進治療解決方案的需求極大地推動了藥物開發和結構生物學對 X光結晶的需求。該技術的準確性和有效性使其對於學術和商業研究至關重要。

科技如何增強 X光結晶的能力？

最近的技術進步極大地提高了 X光結晶的能力。同步加速器輻射和先進檢測器等高強度 X光源的發展提高了資料收集的解析度和速度，使得研究最具挑戰性的生物結構成為可能。此外，人工智慧和機器學習演算法在資料分析中的整合正在加速複雜結晶資料的解釋並減少結構確定所需的時間。由於這些技術進步，X光結晶的應用範圍正在從傳統的藥物發現和蛋白質工程擴展到奈米技術和量子化學等新領域。

X光結晶市場面臨哪些挑戰？

X光結晶市場面臨多項挑戰，特別是在成本、樣品製備和技術限制方面。特別是基於同步加速器的X光結晶等先進系統需要較高的設備和維護成本，這限制了它們只能在資金雄厚的研究機構和大型製藥公司中使用。此外，該技術需要高度精製的結晶樣品，使得樣品製備變得困難且耗時，特別是對於膜蛋白和其他複雜分子。此外，X光照射會損壞脆弱的生物檢體，影響結果的準確性。這些挑戰導致了互補技術的發展，例如冷凍電子顯微鏡 (cryo-EM)，它可以不受 X光結晶的限制來獲得類似的結構資訊。

X光結晶市場的成長受到多種因素的推動。

X光結晶市場的成長受到多種因素的推動，包括藥物發現和結構生物學需求的增加、X光源和檢測器的技術進步以及對個人化醫療的日益重視。製藥業專注於開發複雜疾病的標靶治療是 X 光結晶的主要驅動力。同步加速器輻射和 X光自由電子雷射 (XFEL) 技術的進步正在提高結晶研究的準確性和效率。此外，人工智慧和機器學習在資料分析中的整合正在簡化結構確定過程。材料科學領域研究活動的擴大以及新型材料和奈米結構的開發也有助於市場成長，鞏固了 X光結晶作為科學研究重要工具的作用。

受訪企業範例（共41例）

  • 3D Dental
  • Agilent Technologies, Inc.
  • Anton Paar GmbH
  • BioCryst Pharmaceuticals, Inc.
  • Bruker Corporation
  • C4X Discovery
  • Charles River Laboratories International, Inc.
  • Crelux
  • GBC Scientific Equipment Pty., Ltd.
  • Glenbrook Technologies, Inc.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP15708

Global X-Ray Crystallography Market to Reach US$2.0 Billion by 2030

The global market for X-Ray Crystallography estimated at US$937.3 Million in the year 2023, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 11.4% over the analysis period 2023-2030. Pharmaceutical End-Use, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$944.5 Million by the end of the analysis period. Growth in the Biotechnology End-Use segment is estimated at 12.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$251.8 Million While China is Forecast to Grow at 10.5% CAGR

The X-Ray Crystallography market in the U.S. is estimated at US$251.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$303.3 Million by the year 2030 trailing a CAGR of 10.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.1% and 9.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global X-Ray Crystallography Market - Key Trends & Drivers Summarized

What Makes X-Ray Crystallography Vital in Scientific Research?

X-ray crystallography is a powerful analytical technique used to determine the atomic and molecular structure of a crystal. It is an essential tool in scientific research, particularly in fields such as chemistry, biology, and material science. The ability to understand molecular structures at an atomic level is crucial for drug discovery, protein analysis, and materials development. The pharmaceutical industry extensively uses X-ray crystallography to identify the structure of biological macromolecules, which aids in developing targeted drugs. The increasing prevalence of complex diseases and the need for advanced therapeutic solutions have significantly driven the demand for X-ray crystallography in drug development and structural biology. This technique's precision and effectiveness make it indispensable for academic and commercial research.

How Is Technology Enhancing the Capabilities of X-Ray Crystallography?

Recent technological advancements have greatly enhanced the capabilities of X-ray crystallography. The development of high-intensity X-ray sources, such as synchrotron radiation, and advanced detectors have improved the resolution and speed of data collection, making it possible to study even the most challenging biological structures. Moreover, the integration of artificial intelligence and machine learning algorithms in data analysis is accelerating the interpretation of complex crystallographic data, reducing the time required for structural determination. These technological advancements are expanding the scope of X-ray crystallography applications, from traditional drug discovery and protein engineering to new fields such as nanotechnology and quantum chemistry.

What Challenges Does the X-Ray Crystallography Market Face?

The X-ray crystallography market faces several challenges, particularly related to cost, sample preparation, and technological limitations. The high cost of equipment and maintenance, especially for advanced systems like synchrotron-based X-ray crystallography, limits its accessibility to well-funded research institutions and large pharmaceutical companies. Moreover, the technique requires highly purified crystalline samples, which can be difficult and time-consuming to prepare, particularly for membrane proteins and other complex molecules. Additionally, X-ray radiation can damage sensitive biological samples, potentially affecting the accuracy of the results. These challenges are driving the development of complementary techniques such as cryo-electron microscopy (cryo-EM), which can provide similar structural information without some of the limitations of X-ray crystallography.

The Growth in the X-Ray Crystallography Market Is Driven by Several Factors

The growth in the X-ray crystallography market is driven by several factors, including increasing demand in drug discovery and structural biology, technological advancements in X-ray sources and detectors, and the growing emphasis on personalized medicine. The pharmaceutical industry's focus on developing targeted therapies for complex diseases is a major driver for X-ray crystallography. Advances in synchrotron and X-ray free-electron laser (XFEL) technologies are enhancing the precision and efficiency of crystallographic studies. Additionally, the integration of AI and machine learning in data analysis is streamlining the structural determination process. The expansion of research activities in material science and the development of novel materials and nanostructures are also contributing to the market's growth, solidifying X-ray crystallography's role as a critical tool in scientific research.

Select Competitors (Total 41 Featured) -

  • 3D Dental
  • Agilent Technologies, Inc.
  • Anton Paar GmbH
  • BioCryst Pharmaceuticals, Inc.
  • Bruker Corporation
  • C4X Discovery
  • Charles River Laboratories International, Inc.
  • Crelux
  • GBC Scientific Equipment Pty., Ltd.
  • Glenbrook Technologies, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • X-Ray Crystallography - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for X-Ray Crystallography in Drug Discovery and Development
    • Technological Advancements in X-Ray Sources and Detectors Enhancing Accuracy
    • Growing Importance of X-Ray Crystallography in Structural Biology and Protein Analysis
    • Expansion of Crystallography Applications in Material Science and Nanotechnology
    • Development of Automated and High-Throughput Crystallography Systems
    • Impact of AI and Machine Learning in Crystallography Data Analysis
    • Increasing Investments in Academic and Industrial Research Facilities
    • Emergence of Complementary Techniques Such as Cryo-Electron Microscopy
    • Rising Demand for Personalized Medicine Driving Structural Analysis Needs
    • Opportunities for X-Ray Crystallography in Quantum and Molecular Chemistry
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World X-Ray Crystallography Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for X-Ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for X-Ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for X-Ray Crystallography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Pharmaceutical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Pharmaceutical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Biotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Biotechnology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for X-Ray Crystallography by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for X-Ray Crystallography by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for X-Ray Crystallography by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Rest of Europe 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • X-Ray Crystallography Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Asia-Pacific 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for X-Ray Crystallography by End-Use - Pharmaceutical, Biotechnology and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of World 16-Year Perspective for X-Ray Crystallography by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical, Biotechnology and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION